Effects of mosapride citrate on patients after vagal nerve preserving distal gastrectomy reconstructed by interposition of a jejunal J pouch with a jejunal conduit for early gastric cancer

World Journal of Surgery

Volumn 30, Issue 2, 2006, Pages 205-212

  Tomita, Ryouichi ^a,b   Ikeda, Taro ^b   Fujisaki, Shigeru ^b   Koshinaga, Tugumichi ^b   Tanjoh, Katsuhisa ^b  

^a NIPPON DENTAL UNIVERSITY   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MOSAPRIDE CITRATE;

ABDOMINAL PAIN; ADULT; AGED; APPETITE; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ESOPHAGITIS; FEMALE; GASTRECTOMY; HUMAN; INTERVIEW; ISOTOPE TRACING; JEJUNUM; LYMPH NODE; MALE; NAUSEA; PATIENT SATISFACTION; POSTOPERATIVE PERIOD; QUALITY OF LIFE; STOMACH CANCER; VAGUS NERVE;

ADULT; AGED; BENZAMIDES; COHORT STUDIES; COLONIC POUCHES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; GASTRIC EMPTYING; HUMANS; MALE; MIDDLE AGED; MORPHOLINES; PATIENT SATISFACTION; PERISTALSIS; POSTGASTRECTOMY SYNDROMES; PROBABILITY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STOMACH; STOMACH NEOPLASMS; TREATMENT OUTCOME; VAGUS NERVE;

EID: 31544479561     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-005-7979-6     Document Type: Article

References (36)

1. Japanese Research Society for Gastric Cancer Japanese Classification of Gastric Carcinoma (1st English edition) Tokyo Kanehara, 1995;7-16.
2. Fukuhara H, Imamaura H, Kodera K. The role of surgery in the current treatment of gastric cancer. Gastric Cancer 2002;5:13-16.
3. Shimoyama S, Seto Y, Yasuda H, et al. Concepts, rationale, and current outcomes of less invasive surgical strategies for early gastric cancer: data from a quarter-century of experience in a single institution. World J Surg 2005;29:58-65.
4. Woodward ER, Hocking MP. Postgastrectomy syndromes. Surg Clin North Am 1987;67:509-520.
5. Wu CW, Hsieh MC, Lo SS, et al. Quality of life of patients with gastric adenocarcinoma after curative gastrectomy. World J Surg 1997;21:777-782.
6. Tomita R, Fujisaki S, Tanjoh K, et al. Relationship between gastroduodenal interdigestive migrating motor complex and quality of life in patients with subtotal gastrectomy for early gastric cancer. Int Surg 2000;85:118-123.
7. Nishikawa K, Kawahara H, Yumiba T, et al. Functional characteristics of the pylorus in patients undergoing pylorus-preserving gastrectomy for early gastric cancer. Surgery 2002;131:613-624.
8. Takahashi T, Yoshida M, Kubota T, et al. Morphologic analysis of gastroesophageal reflux diseases in patients after distal gastrectomy. World J Surg 2005;29:50-57.
9. Ohya T, Ohwada S, Iesato H, et al. Jejunal pouch interposition after pylorus-preserving gastrectomy. J Surg Res 1999;86:177-182.
10. Iezato H, Ohya T, Ohwada S, et al. Jejunal pouch interposition with an antiperistaltic conduit as a pyloric ring substitute after standard distal gastrectomy: a comparison with the use of an isoperistaltic conduit. Hepatogastroenterology 2000;47:756-760.
11. Mori Y, Arita T, Shimoda K, et al. Jejunal interposition to prevent postgastrectomy syndroms. Br J Surg 2000;87:1576-1579.
12. Hida Y, Katoh H. New method for the jejunal pouch interposition reconstruction after distal gastrectomy. Hepatogastroenterology 2000;47:1495-1497.
13. Nomura E, Shinohara H, Mabuchi H, et al. Postoperative evaluation of the jejunal pouch reconstruction following proximal and distal gastrectomy for gastric cancer. Hepatogastroenterology 2004;59:1561-1566.
14. Nakane Y, Michiura T, Inoue K, et al. A randomized clinical trial of pouch reconstruction after total gastrectomy for cancer: which is better technique, Roux-en-Y or interposition? Hepatogastroenterology 2001;48:903-907.
15. Ueno M, Iwahashi M, Nakamori M, et al. Complication of jejunal pouch interposition after proximal gastrectomy: case report. Hepatogastroenterology 2004;57:916-918.
16. Tomita R, Tanjoh K, Fujisaki S. Novel operative technique for vagal nerve- and pyloric sphincter-preserving distal gastrectomy reconstructed by interpostion of a 5 cm jejunal J pouch with a 3 cm jejunal conduit for early gastric cancer and postoperative quality of life 5 years after operation. World J Surg 2004;28:766-774.
17. Tomita R, Tanjoh K, Fujisaki S. Relation between gastroduodenal interdigestive migrating motor complex and post-operative gastrointestinal symptoms before and after cisapride therapy following distal gastrectomy for early gastric cancer. World J Surg 2000;24:1250-1257.
18. Ramkumar D, Schulze KS. Gastrointestinal motility. Current Opin Gastroenterol 2003;19:540-545.
19. Cuomo R, Sarnelli G. Food intake and gastrointestinal motility. A complex interplay. Nutr Metab Cardiovasc Dis 2004;14:173-179.
20. Sakashita M, Yamaguchi T, Miyazaki H, et al. Pharmacokinetics of the gastrokinetic agent mosapride citrate after single and multiple oral administrations in healthy subjects. Arzneimittelforschung 1993;43:867-872.
21. Endo J, Nomura N, Morishita S, et al. Influence of mosapride citrate on gastric motility and autonomic nerves functions: evaluation by spectral analyses of heart rate and blood pressures, and by electrogastrography. J Gastroenterol 2002;37:888-895.
22. Asakawa H, Hayashi I, Fukui T, et al. Effect of mosapride on glycemic control and gastric emptying in type 2 diabetes mellitus patients with gastropathy. Diabetes. Res. Clin. Pract. 2003;61:175-182.
23. Maki T, Shiratori T, Hatafuku T, et al. Pylorus-preserving gastrectomy as an improved operation for gastric cancer. Surgery 1967;61:838-845.
24. Tomita R, Takizawa H, Tanjoh K. Physiological effects of cisapride on gastric emptying after pylorus-preserving gastrectomy for early gastric cancer. World J Surg 1998;22:35-40.
25. Imada T, Rino Y, Takahashi M, et al. Postoperative functional evaluation of pylorus-preserving gastrectomy for early gastric cancer compared with comventional distal gastrectomy. Surgery 1998;123:165-170.
26. Tomita R, Fujisaki S, Tanjoh K. An operative technique on nearly total gastrectomy reconstructed by interposition of a jejunal J pouch with preservation of vagal nerve, lower esophageal sphincter and pyloric sphincter for early gastric cancer. World J Surg 2001;25:1524-1531.
27. Behrns KE, Sarr MG. Diagnosis and management of gastric emptying disorders. Adv Surg 1994;27:233-255.
28. Forstner-Barthell AW, Murr MM, Nitecki S, et al. Near-total gastrectomy for severe postvagotomy gastric stasis: analysis of early and long-term results in 62 patients. J Gastrointest Surg 1999;3:15-21.
29. Tomita R, Munakat K, Kurosu Y, et al. Gastric emptying time after distal gastrectomy with or without pylorus-preserving. J Smooth Muscle Res 1994;20:229-231.
30. Ruth M, Finizia C, Cange L, et al. The effect of mosapride on esophageal motor function and acid reflux in patients with gastroesophageal reflux disease. Eur J Gastroenterol Hepatol 2003;15:1115-1121.
31. Madan K, Ahuja V, Kashyap PC, et al. Comparison of efficiency of pantoprazole alone versus pantoprazole pulus mosapride in therapy of gastroesophageal reflux disease: a randomized trial. Dis Esophagus 2004;17:274-278.
32. Mine Y, Yoshikawa T, Oku S, et al. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro. J Pharmacol Exp Ther 1997;283:1000-1008.
33. 99mTc-tagged chicken liver as a maker of solid food in human stomach. Dig Dis Sci 1976;21:296-230.
34. Shiratori T, Hongo M, Ishii M. Interpretation of gastric emptying curve by Rl method. J Smooth Muscle Res 1994;30:433-437.
35. Calvert EL, Whorwell PJ, Houghton LA. Inter-digestive and post-prandial antro-pyloro-duodenal motor activity in humans: effect of 5-hydroxytryptamine 1 receptor agonist. Aliment Pharmacol Ther 2004;19:805-815.
36. Itoh H, Nagano T, Takeyama M. Effects of mosapride citrate on human plasma levels of motilin, gastrin, somatostatin, and secretin. Biol Pharm Bull 2001;24:1072-1075.